{
    "organizations": [],
    "uuid": "b3b57592ee40e03c914751cef1df8f56a5250117",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-acceleron-begins-phase-2-trial-of/brief-acceleron-begins-phase-2-trial-of-pulmonary-arterial-hypertension-treatment-idUSASC0A36J",
    "ord_in_thread": 0,
    "title": "BRIEF-Acceleron Begins Phase 2 Trial Of Pulmonary Arterial Hypertension Treatment",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - Acceleron Pharma Inc:\n* ACCELERON ANNOUNCES INITIATION OF PULSAR PHASE 2 TRIAL OF SOTATERCEPT IN PULMONARY ARTERIAL HYPERTENSION\n* ACCELERON PHARMA - PLANS TO REPORT PRELIMINARY RESULTS FROM 6-MONTH PRIMARY TREATMENT PERIOD OF PULSAR PHASE 2 TRIAL IN FIRST HALF OF 2020 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T19:09:00.000+03:00",
    "crawled": "2018-05-23T15:22:49.038+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "acceleron",
        "pharma",
        "inc",
        "acceleron",
        "announces",
        "initiation",
        "pulsar",
        "phase",
        "trial",
        "sotatercept",
        "pulmonary",
        "arterial",
        "hypertension",
        "acceleron",
        "pharma",
        "plan",
        "report",
        "preliminary",
        "result",
        "primary",
        "treatment",
        "period",
        "pulsar",
        "phase",
        "trial",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}